Moroccan pharmaceutical company Cooper Pharma has launched a digital platform called "Ach Khbar Sukkar" to raise awareness about type 2 diabetes. The platform was presented in Casablanca on Thursday in the presence of two specialists, Professor Asmaa Chadli and Professor Hinde Iraqi. The initiative aims to make prevention and therapeutic education messages more accessible to patients and their families.
According to the Ministry of Health and Social Protection, approximately 2.5 million Moroccans are living with diabetes, which is estimated to be 10.6% of the adult population. Additionally, nearly 2.2 million people are in a prediabetic state. The disease poses significant challenges in terms of screening, medical follow-up, and prevention of complications.
A study conducted in Fez in 2015 showed that 33.4% of patients had already developed complications at the time of diagnosis, and 47.7% developed complications after diagnosis. Another study found that 38.8% of patients had never consulted an ophthalmologist, highlighting the difficulties in prevention and follow-up. These results emphasize the need to improve patient information and education.
The "Ach Khbar Sukkar" platform takes a pedagogical approach that avoids anxiety-provoking messages while emphasizing the risks associated with the disease. It features three characters inspired by Moroccan daily life and offers content adapted to patients' sociocultural realities. The content is available in Darija, Arabic, and French, and includes short videos, educational carousels, quizzes, and testimonials.
The platform's goal is to facilitate the understanding of medical information and encourage patients to take a more active role in managing their disease. This approach leverages the growing use of digital technologies in Morocco, with 91.4% of the population owning a smartphone and 92% having internet access.
Cooper Pharma emphasizes that the content on the platform is documented, sourced, and validated by Moroccan experts. The company aims to provide reliable information and support to patients, while addressing the challenges of diabetes management in Morocco.
The launch of "Ach Khbar Sukkar" marks a new approach to diabetes awareness and education in Morocco. By using digital technologies and adapting to patients' needs, Cooper Pharma hopes to make a positive impact on the lives of those affected by the disease.
Key points
- The platform "Ach Khbar Sukkar" offers content in Darija, Arabic, and French to cater to Morocco's diverse population.
- Approximately 2.5 million Moroccans are living with diabetes, with 10.6% of the adult population affected.
- The platform aims to encourage patients to take a more active role in managing their disease through education and awareness.
